Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer

No abstract is available for this paper.

• Publication year

  2007

• Venue

  European Respiratory Journal

• Publication date

  2007-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1183/09031936.00129306PMID 17537769
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Is the invasive front of an oral carcinoma the most important area for prognostication?

  2008cited by this paper
• Inflammation and prognosis in colorectal cancer.

  2005cited by this paper
• Clinical practice. Lung cancer screening.

  2005cited by this paper
• Cancer Statistics, 2005

  2005cited by this paper
• Differential expression of IL‐10 receptor by epithelial cells and alveolar macrophages

  2004cited by this paper
• Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression.

  2004cited by this paper
• Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis

  2004cited by this paper
• Trends in mortality from major cancers in the European Union, including acceding countries, in 2004

  2004cited by this paper
• Lack of interleukin-10 expression could predict poor outcome in patients with stage I non-small cell lung cancer.

  2003cited by this paper
• Gene expression in lung adenocarcinomas of smokers and nonsmokers.

  2003cited by this paper
• Prognostic factors in non-small cell lung cancer: a decade of progress.

  2002cited by this paper
• Significant correlation between interleukin 10 expression and vascularization through angiopoietin/TIE2 networks in non-small cell lung cancer.

  2001cited by this paper
• Tumor Rejection by Disturbing Tumor Stroma Cell Interactions

  2001cited by this paper
• The new World Health Organization classification of lung tumours

  2001cited by this paper
• Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10.

  2000cited by this paper
• Autocrine Production of IL-10 Mediates Defective IL-12 Production and NF-κB Activation in Tumor-Associated Macrophages1

  2000cited by this paper
• Clinical implications of interleukin (IL)-10 induced by non-small-cell lung cancer.

  2000cited by this paper
• Microglial/macrophage expression of interleukin 10 in human glioblastomas

  1999cited by this paper
• Tumor-induced interleukin-10 inhibits type 1 immune responses directed at a tumor antigen as well as a non-tumor antigen present at the tumor site.

  1999cited by this paper
• Tumor-Associated Macrophage Infiltration in Pulmonary Adenocarcinoma: Association with Angiogenesis and Poor Prognosis

  1999cited by this paper
• The invasive front of carcinomas. The most important area for tumour prognosis?

  1998cited by this paper
• Interleukin‐10 is a growth factor for human melanoma cells and down‐regulates HLA class‐I, HLA class‐II and ICAM‐1 molecules

  1997cited by this paper
• Revisions in the International System for Staging Lung Cancer.

  1997cited by this paper
• Immunosuppressive cytokines (IL‐10, TGF‐β) genes expression in human gastric carcinoma tissues

  1996cited by this paper
• Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis.

  1995cited by this paper
• Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas.

  1995cited by this paper
• Interleukin‐10 is a potent inhibitor of tumor cytotoxicity by human monocytes and alveolar macrophages

  1994cited by this paper
• IL-10 inhibits cytokine production by activated macrophages.

  1991cited by this paper
• Statistics in respiratory medicine. 2. Repeatability and method comparison.

  1991cited by this paper
• Macrophage deactivation by interleukin 10

  1991cited by this paper
• Cancer statistics

  1989cited by this paper

• Unraveling the molecular-pathological characteristics and cellular complexity of the tumor immune microenvironment in metastatic non-small cell lung cancer

  2025cites this paper
• Targeting myeloid cell immunometabolism to improve current non-small cell lung cancer therapies.

  2025cites this paper
• PYGO2 regulates IL10 and plays immunosuppressive role through ESCC progression

  2025cites this paper
• Modulation of macrophage metabolism as an emerging immunotherapy strategy for cancer

  2024cites this paper
• The complex role of IL-10 in malignant ascites: a review

  2024cites this paper
• Tumor-derived miR-6794-5p enhances cancer growth by promoting M2 macrophage polarization

  2024cites this paper
• Cinobufagin inhibits M2-like tumor-associated macrophage polarization to attenuate the invasion and migration of lung cancer cells

  2024cites this paper
• B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors

  2024cites this paper
• Myrtenol ameliorates inflammatory, oxidative, apoptotic, and hyperplasic effects of urethane-induced atypical adenomatous hyperplasia in the rat lung

  2024cites this paper
• Serum progastrin-releasing peptide in pneumonia, chronic obstructive pulmonary disease and early-stage primary lung cancers

  2024cites this paper
• Interleukin-10 deficiency suppresses colorectal cancer metastasis by enriching gut Parabacteroides distasonis

  2024cites this paper
• The HDAC2-SP1 axis orchestrates pro-tumor macrophage polarization.

  2023cites this paper
• The Nexus of Inflammation-Induced Epithelial-Mesenchymal Transition and Lung Cancer Progression: A Roadmap to Pentacyclic Triterpenoid-Based Therapies

  2023cites this paper
• Correlation of Protumor Effects of Leucine-Rich Repeat Kinase 2 with Interleukin-10 Expression in Lung Squamous Cell Carcinoma

  2023cites this paper
• Telomerase deficiency and dysfunctional telomeres in the lung tumor microenvironment impair tumor progression in NSCLC mouse models and patient-derived xenografts

  2023cites this paper
• Immunometabolic attributes and mitochondria-associated signaling of Tumor-Associated Macrophages in tumor microenvironment modulate cancer progression.

  2022cites this paper
• Characteristics of tumor microenvironment and novel immunotherapeutic strategies for non-small cell lung cancer

  2022cites this paper
• IL-10 in cancer: an essential thermostatic regulator between homeostatic immunity and inflammation - a comprehensive review.

  2022cites this paper
• TNFSF15 facilitates differentiation and polarization of macrophages toward M1 phenotype to inhibit tumor growth

  2022cites this paper
• SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation

  2021cites this paper
• OTT_A_286274 1033..1048

  2021cites this paper
• Multicellular Effects of STAT3 in Non-small Cell Lung Cancer: Mechanistic Insights and Therapeutic Opportunities

  2021cites this paper
• The Potential Advantage of Targeting Both PD-L1/PD-L2/PD-1 and IL-10–IL-10R Pathways in Acute Myeloid Leukemia

  2021cites this paper
• TCN1 is a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma

  2021cites this paper
• NRAS expression is associated with prognosis and tumor immune microenvironment in lung adenocarcinoma

  2021cites this paper
• Dysregulation of cholesterol homeostasis in human lung cancer tissue and tumour-associated macrophages

  2021cites this paper
• Sex Hormones and Lung Inflammation.

  2021cites this paper
• The Role of Tumor Inflammatory Microenvironment in Lung Cancer

  2021cites this paper
• A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications

  2021cites this paper
• Myeloid cell-derived PROS1 inhibits tumor metastasis by regulating inflammatory and immune responses via IL-10.

  2021cites this paper
• Exonuclease 1 (EXO1) is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Lung Adenocarcinoma

  2021cites this paper
• The Crosstalk Between Tumor-Associated Macrophages (TAMs) and Tumor Cells and the Corresponding Targeted Therapy

  2020cites this paper
• Prognostic Value of Innate and Adaptive Immunity in Cancers

  2020cites this paper
• Thioholgamide A, a New Anti-Proliferative Anti-Tumor Agent, Modulates Macrophage Polarization and Metabolism

  2020influential citation
• LC3-Associated Phagocytosis (LAP): A Potentially Influential Mediator of Efferocytosis-Related Tumor Progression and Aggressiveness

  2020cites this paper
• IL-10 suppresses IFN-γ-mediated signaling in lung adenocarcinoma

  2020cites this paper
• Antibody combinations for optimized staining of macrophages in human lung tumours

  2020cites this paper
• Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk

  2020cites this paper
• IL10 as Cancer Biomarker

  2020cites this paper
• Transcription factor MafB is a marker of tumor-associated macrophages in both mouse and humans.

  2020cites this paper
• Microenvironmental modulation of the developing tumour: an immune‐stromal dialogue

  2020cites this paper
• Myeloid-Derived Suppressor Cells Promote Metastasis in Breast Cancer After the Stress of Operative Removal of the Primary Cancer

  2019cites this paper
• Innate and Adaptive Immune Responses to Cancer

  2019cites this paper
• Lung cancer stem cells: origin, features, maintenance mechanisms and therapeutic targeting

  2019cites this paper
• The effects of smoking on vascular endothelial growth factor and inflammation markers: A case‐control study

  2018cites this paper
• NSCLC: a target Population for a multivalent NY-ESO-1, CT7/MAGE-C1 and CT10/MAGE-C2 vaccine

  2018cites this paper
• Interleukin-10-regulated tumour tolerance in non-small cell lung cancer

  2017cites this paper
• Epiregulin is required for lung tumor promotion in a murine two‐stage carcinogenesis model

  2017cites this paper
• Regulation of tumor progression and metastasis by bone marrow-derived microenvironments

  2017cites this paper
• Biomarkers of the Tumor Microenvironment

  2017cites this paper
• Evènements moléculaires spécifiques au cours des adénocarcinomes pulmonaires lépidiques humains et animaux

  2017cites this paper
• Tumor-Associated Macrophages and Myeloid-Derived Suppressor Cells as Immunosuppressive Mechanism in Ovarian Cancer Patients: Progress and Challenges

  2016cites this paper
• The re-polarisation of M2 and M1 macrophages and its role on cancer outcomes.

  2016cites this paper
• Characterization of M1/M2 Tumour-Associated Macrophages (TAMs) and Th1/Th2 Cytokine Profiles in Patients with NSCLC

  2016cites this paper
• Monocytic myeloid-derived suppressor cells as a potent suppressor of tumor immunity in non-small cell lung cancer.

  2016cites this paper
• Inverse role of distinct subsets and distribution of macrophage in lung cancer prognosis: a meta-analysis

  2016cites this paper
• Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers.

  2016cites this paper
• Tissue-resident versus monocyte-derived macrophages in the tumor microenvironment.

  2016cites this paper
• Effects of Thyroid Stimulating Hormone on Tumor Growth by Modulating Tumor Microenvironment in Thyroid Cancer

  2016cites this paper
• Cytokines, Chemokines, and Chemokine Receptors Quantitative Expressions in Patients with Ovarian Cancer

  2015cites this paper
• The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome.

  2015cites this paper
• Rôle de l’éctonucléotidase CD39 dans l’acquisition d’un phénotype immunorégulateur par les macrophages associés aux tumeurs

  2015cites this paper
• Cancers with Higher Density of Tumor-Associated Macrophages Were Associated with Poor Survival Rates

  2015cites this paper
• Targeting roles of inflammatory microenvironment in lung cancer and metastasis

  2015cites this paper
• Intrapulmonary Delivery of CpG Microparticles Eliminates Lung Tumors

  2015cites this paper
• Regulation of epithelial-mesenchymal transition by tumor-associated macrophages in cancer.

  2015cites this paper
• Cancer bronchique et inflammation

  2015cites this paper
• Inflammation and Lung Cancer: Prevention

  2015cites this paper
• The Utilization of Cytologic Fine-Needle Aspirates of Lung Cancer for Molecular Diagnostic Testing

  2015cites this paper
• How to target small cell lung cancer

  2015cites this paper
• Poly(I:C) and CpG-ODN combined aerosolization to treat lung metastases and counter the immunosuppressive microenvironment

  2015cites this paper
• Macrophage phenotype and function in primary lung cancer

  2015cites this paper
• Innate and Adaptive Immune Responses to Cancer

  2014cites this paper
• Improving AAV Gene Therapy: Graduating From Transgene Expression “Everywhere, All The Time” To “Disease-Specific”

  2014cites this paper
• Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties.

  2014cites this paper
• Interleukin-10 (IL-10) promoter genotypes are associated with lung cancer risk in Taiwan males and smokers.

  2014cites this paper
• The hypoxic tumor microenvironment: driving the tumorigenesis of non-small-cell lung cancer.

  2014cites this paper
• Inhibition of tumor angiogenesis by interferon-γ by suppression of tumor-associated macrophage differentiation.

  2014cites this paper
• Comparison of Efficacy of the Disease-Specific LOX1- and Constitutive Cytomegalovirus-Promoters in Expressing Interleukin 10 through Adeno-Associated Virus 2/8 Delivery in Atherosclerotic Mice

  2014cites this paper
• The role of inflammation in lung cancer.

  2014cites this paper
• New modalities of cancer treatment for NSCLC: focus on immunotherapy

  2014cites this paper
• BMP-6 in renal cell carcinoma promotes tumor proliferation through IL-10-dependent M2 polarization of tumor-associated macrophages.

  2013influential citation
• Human Cancer Biology IL-10 Promotes Tumor Aggressiveness via Upregulation of CIP 2 A Transcription in Lung Adenocarcinoma

  2013cites this paper
• The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer.

  2013cites this paper
• Anti‐tumor activity of CpG‐ODN aerosol in mouse lung metastases

  2013cites this paper
• Activation of Thromboxane A2 Receptor (TP) Increases the Expression of Monocyte Chemoattractant Protein -1 (MCP-1)/Chemokine (C-C motif) Ligand 2 (CCL2) and Recruits Macrophages to Promote Invasion of Lung Cancer Cells

  2013cites this paper
• Glioma Grade Is Associated with the Accumulation and Activity of Cells Bearing M2 Monocyte Markers

  2013cites this paper
• IL-10 Promotes Tumor Aggressiveness via Upregulation of CIP2A Transcription in Lung Adenocarcinoma

  2013cites this paper
• Tumor-associated macrophages in thoracic malignancies.

  2013cites this paper
• Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer.

  2012cites this paper
• Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature

  2012cites this paper
• MOLECULAR MECHANISMS OF THROMBOXANE A2 RECEPTOR-MEDIATED INVASION IN LUNG CANCER CELLS

  2012cites this paper
• Review Article Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer

  2012cites this paper
• High expression of tumor-infiltrating macrophages correlates with poor prognosis in patients with diffuse large B-cell lymphoma

  2012cites this paper
• Interleukin-10 Haplotype May Predict Survival and Relapse in Resected Non-Small Cell Lung Cancer

  2012cites this paper
• IL-10 Immunomodulation of Myeloid Cells Regulates a Murine Model of Ovarian Cancer

  2011influential citation
• Identification and manipulation of tumor associated macrophages in human cancers

  2011cites this paper
• Lung Cancer-Derived Galectin-1 Mediates Dendritic Cell Anergy through Inhibitor of DNA Binding 3/IL-10 Signaling Pathway

  2011cites this paper
• Interleukin 10 (IL-10) Regulatory Cytokine and its Clinical Consequences

  2011cites this paper
• Prognostic Immune Markers in Non–Small Cell Lung Cancer

  2011cites this paper